Severance Hospital
Seoul, 120-752, South Korea
NCT Number: NCT01269268
There was no sensitive and specific biomarker for tuberculosis infection, disease progression and predicting the prognosis of treatment. Therefore, the investigators aimed to investigate and evaluate the newer biomarker for the diagnosis of TB infection. To investigate the new biomarker for TB infection, the investigators will recruit the participants including active TB patients, healthy household contacts, healthy community control.
Looking for future studies?
Notify Me20 year–75 year
All sexes
Observational
Seoul, 120-752, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6months
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02639936
Actinomycetales Infections, Active Tuberculosis
Copenhagen, Denmark
View Trial DetailsNCT06408129
Actinomycetales Infections, Active Tuberculosis
Montpellier, France
View Trial DetailsNCT04048018
Actinomycetales Infections, Active Tuberculosis
Palo Alto, California, United States
View Trial DetailsNCT03271567
Actinomycetales Infections, Active Tuberculosis
Shatin, Hong Kong
View Trial Details